Actively Recruiting
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Led by Nanfang Hospital, Southern Medical University · Updated on 2025-05-25
3000
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
Sponsors
N
Nanfang Hospital, Southern Medical University
Lead Sponsor
S
Southern Medical University, China
Collaborating Sponsor
AI-Summary
What this Trial Is About
Spondyloarthritis(SpA) patients attending Nanfang Hospital of Southern Medical University will generate a large number of clinical condition scales, laboratory indicators, imaging data such as X-rays or MRIs in the course of multiple standardized follow-up visits, as well as medical specimens from some of the patients who undergo surgical treatments. The Department of Orthopaedic Surgery of Nanfang Hospital is looking forward to the future and proposes to establish a specialized cohort named "Nanfang SpA Bidirectional Specialized Disease Cohort" by simply recording the clinical and imaging data of the above patients who have attended the clinic, been treated routinely, and have been followed up in the department without any interventional research measures. The cohort is proposed to: (1) archive the disease characteristics, biochemical index data, and disease assessment scales of all SpA patients attending the Southern Hospital; (2) record the X-ray and magnetic resonance imaging data of the patients to establish the "Southern SpA Imaging Dataset". This provides strong support for subsequent SpA research projects and lays the foundation for subsequent large-scale transect studies and retrospective studies.
CONDITIONS
Official Title
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Attended Nanfang Hospital, Southern Medical University between 2010 and 2030
- For prospective cohort: voluntarily agree and sign informed consent
- For retrospective cohort: patients from April 2010 to April 2024 exempted from consent; patients from May 2024 to April 2025 must sign consent
- Age between 10 and 59 years
- Diagnosed with spondyloarthritis according to 2009 ASAS axial or 2011 ASAS peripheral classification criteria
You will not qualify if you...
- Women who are pregnant, planning pregnancy, or breastfeeding
- Moderate to severe heart failure (New York Heart Association Class 3-4)
- Active peptic ulcers or bleeding
- Investigator judgment deeming participant unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanfang Hostipal,Southern Medical University
Guangzhou, Guangdong, China, 510515
Actively Recruiting
Research Team
J
Jun Xiao, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here